Patient with suspected zika could not donate blood for 30 days

By Natália Cancian, Folha de S. Paulo 2015/12/22

The measures occur after the Blood Center of Unicamp (University of Campinas) report on Tuesday (15), a patient was infected by zika virus after receiving blood transfusion from a donor with the disease. According to Folha revealed, an examination of the Adolfo Lutz Institute confirmed the infection, which occurred in March this year. The acquired zika patient, however, did not have symptoms of the disease.

http://http://www1.folha.uol.com.br/cotidiano/2015/12/1722108-paciente-com-suspeita-de-zika-nao-vai-poder-doar-sangue-por-30-dias.shtml

Protocol

Anemia Treatment and Erythropoietin therapy Guidelines

Protocol based on scientific evidence for the non-transfusional treatment of anemia through the appropriate use of iron and erythropoietin.

Welcome to Bloodless

Background:

Blood transfusions are currently one of the most performed medical procedures in the world. However, the medical literature shows a relationship between the use of allogeneic (donated) blood and greater complications, including, greater mortality. Worldwide, there is a deficiency in medical knowledge about transfusion practice.

Objectives:

1. To change the current transfusion practice, through the application of scientifically safe and effective PROTOCOLS for the TREATMENT OF ANEMIA and MANAGEMENT OF BLEEDING without the use of allogeneic blood, based on the scientific evidence of modern medicine.

2. Help blood banks SAVE their main HEMOCOMPONENTS (red blood cells, plasma and platelets)